Pfizer Raises Quarterly Dividend to $0.43, Offering 6.66% Yield
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Market Mixed on Friday the 13th | Livestock
Pfizer Announces Results From PATINA Trial
SABCS: Pfizer's IBRANCE Combo Improves PFS in Breast Cancer Study
Express News | Evonik Industries - to Organize Its Business Lines in Two New Segments: Custom Solutions and Advanced Technologies
Express News | Evonik Industries - to Reduce Number of Management Levels From Average of Ten to Maximum of Six by End of 2026
Express News | Evonik Industries - Both Segments Currently Have Annual Sales of Around EUR 6 Bln Each
Express News | Evonik Industries CEO: 2024 Is a Good Year for Evonik
Pfizer To Go Ex-Dividend On January 24th, 2025 With 0.43 USD Dividend Per Share
Pfizer announced an increase in the quarterly dividend.
The American pharmaceutical giant Pfizer announced on Thursday that it will increase the quarterly dividend by 2.4%, from 42 cents per share to 43 cents. The new dividend amounts to $1.72 per year, implying an annual yield of approximately 6.8%. Pfizer's CEO Albert Bourla stated that the increase in dividend highlights the company's strong financial performance, execution capabilities, and commitment to returning capital to shareholders.
Pfizer Boost Quarter Dividend by 2.4% to 43c
Express News | Pfizer Inc - Increases Quarterly Dividend to $0.43 per Share
Press Release: Pfizer Declares First-Quarter 2025 Dividend
Express News | Pfizer Declares First-Quarter 2025 Dividend
Pfizer Options Spot-On: On December 12th, 172.12K Contracts Were Traded, With 3.65 Million Open Interest
Thursday Ends in Index Declines | Wall Street Today
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock